SG11202102653WA - Rotomeric isomers of 4-alkyl-5-heteroaryl-3h-1,2- dithiole-3-thiones - Google Patents
Rotomeric isomers of 4-alkyl-5-heteroaryl-3h-1,2- dithiole-3-thionesInfo
- Publication number
- SG11202102653WA SG11202102653WA SG11202102653WA SG11202102653WA SG11202102653WA SG 11202102653W A SG11202102653W A SG 11202102653WA SG 11202102653W A SG11202102653W A SG 11202102653WA SG 11202102653W A SG11202102653W A SG 11202102653WA SG 11202102653W A SG11202102653W A SG 11202102653WA
- Authority
- SG
- Singapore
- Prior art keywords
- dithiole
- thiones
- heteroaryl
- alkyl
- rotomeric
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Toxicology (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862732867P | 2018-09-18 | 2018-09-18 | |
| PCT/IB2019/001138 WO2020058767A1 (en) | 2018-09-18 | 2019-09-17 | Rotomeric isomers of 4-alkyl-5-heteroaryl-3h-1,2- dithiole-3-thiones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202102653WA true SG11202102653WA (en) | 2021-04-29 |
Family
ID=69024428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202102653WA SG11202102653WA (en) | 2018-09-18 | 2019-09-17 | Rotomeric isomers of 4-alkyl-5-heteroaryl-3h-1,2- dithiole-3-thiones |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20210206751A1 (en) |
| EP (1) | EP3853223A1 (en) |
| JP (1) | JP2022501424A (en) |
| KR (1) | KR20210061390A (en) |
| CN (2) | CN113166127A (en) |
| AU (1) | AU2019341666A1 (en) |
| BR (1) | BR112021005010A2 (en) |
| CA (1) | CA3113169A1 (en) |
| EA (1) | EA202190798A1 (en) |
| IL (1) | IL281598A (en) |
| MX (1) | MX2021003123A (en) |
| SG (1) | SG11202102653WA (en) |
| WO (1) | WO2020058767A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202200144A (en) * | 2020-03-16 | 2022-01-01 | 瑞士商Ｓｔ知識產權控股公司 | Rotomeric isomers of 4-alkyl-5-heteroaryl-3h-1,2-dithiole-3-thiones |
| DE202023001038U1 (en) | 2023-05-10 | 2023-06-16 | Rainer Teutenberg | Ballistic and acoustically effective clothing for shooting ranges |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3156369A (en) | 1962-09-19 | 1964-11-10 | Ethicon Inc | Bicameral container |
| IT1292677B1 (en) | 1997-02-28 | 1999-02-11 | Bormioli Metalplast Spa | PACKAGING TO KEEP THE PRODUCTS SEPARATE BEFORE USE. |
| TW200640898A (en) * | 2005-02-24 | 2006-12-01 | Solvay Pharm Bv | Anethole dithiolethione and other dithiolethiones for the treatment of conditions associated with dysfunction of monoamine neurotransmission |
| WO2007010560A1 (en) | 2005-07-15 | 2007-01-25 | Bormioli Rocco & Figlio S.P.A. | A reservoir with a cutter for substances to be mixed with liquids at moment of use, in particular for single-dose containers |
| WO2007121356A2 (en) * | 2006-04-13 | 2007-10-25 | Accu-Break Technologies | Method of treatment with predictably breakable pharmaceutical tablets |
| GB0704718D0 (en) * | 2007-03-12 | 2007-04-18 | Prendergast Patrick T | Compounds and methods for preventing and treating mucositis |
| ES2527604T3 (en) | 2010-02-16 | 2015-01-27 | Teva Branded Pharmaceutical Products R & D, Inc. | An inhalable pharmaceutical composition |
| RU2019110128A (en) | 2012-02-28 | 2019-05-08 | Айсьютика Холдингз Инк. Бви | INHALATION PHARMACEUTICAL COMPOSITIONS |
| AU2014261538A1 (en) | 2013-04-29 | 2015-12-10 | Sanofi Sa | Inhalable pharmaceutical compositions and the inhaler devices containing them |
| WO2016207914A2 (en) | 2015-06-25 | 2016-12-29 | St Ip Holding Ag | Methods for preparing oltipraz |
| CN105327337A (en) * | 2015-10-30 | 2016-02-17 | 中国人民解放军96617部队 | Anti-radiation anti-caries inflammation-diminishing oral preparation |
| WO2018047013A1 (en) * | 2016-09-12 | 2018-03-15 | St Ip Holding Ag | Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1, 2-dithiole-3-thione, and methods of making and using same |
| WO2018047002A1 (en) * | 2016-09-12 | 2018-03-15 | St Ip Holding Ag | Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1.2-dithiole-3-thione, taste-modified formulations, and methods of making and using same |
-
2019
- 2019-09-17 CN CN201980076028.4A patent/CN113166127A/en active Pending
- 2019-09-17 CA CA3113169A patent/CA3113169A1/en active Pending
- 2019-09-17 EA EA202190798A patent/EA202190798A1/en unknown
- 2019-09-17 EP EP19828305.3A patent/EP3853223A1/en active Pending
- 2019-09-17 KR KR1020217011340A patent/KR20210061390A/en unknown
- 2019-09-17 MX MX2021003123A patent/MX2021003123A/en unknown
- 2019-09-17 WO PCT/IB2019/001138 patent/WO2020058767A1/en unknown
- 2019-09-17 BR BR112021005010-8A patent/BR112021005010A2/en not_active Application Discontinuation
- 2019-09-17 AU AU2019341666A patent/AU2019341666A1/en not_active Abandoned
- 2019-09-17 SG SG11202102653WA patent/SG11202102653WA/en unknown
- 2019-09-17 JP JP2021538939A patent/JP2022501424A/en active Pending
- 2019-09-17 CN CN202111092175.6A patent/CN113694068A/en active Pending
-
2021
- 2021-03-17 IL IL281598A patent/IL281598A/en unknown
- 2021-03-18 US US17/205,841 patent/US20210206751A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019341666A1 (en) | 2021-05-13 |
| IL281598A (en) | 2021-05-31 |
| MX2021003123A (en) | 2021-08-11 |
| KR20210061390A (en) | 2021-05-27 |
| US20210206751A1 (en) | 2021-07-08 |
| JP2022501424A (en) | 2022-01-06 |
| CA3113169A1 (en) | 2020-03-26 |
| CN113166127A (en) | 2021-07-23 |
| EP3853223A1 (en) | 2021-07-28 |
| WO2020058767A4 (en) | 2020-06-04 |
| EA202190798A1 (en) | 2021-09-10 |
| CN113694068A (en) | 2021-11-26 |
| WO2020058767A1 (en) | 2020-03-26 |
| BR112021005010A2 (en) | 2021-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL271950A (en) | Polymorphs of 5-fluoro-4-imino-3-methyl-1-tosyl-3,4-dihydropyrimidin-2-one | |
| ZA202004278B (en) | Gis-type zeolite | |
| GB201721172D0 (en) | Compound | |
| IL273387A (en) | Thailanstatin analogs | |
| IL281598A (en) | Rotomeric isomers of 4-alkyl-5-heteroaryl-3h-1,2- dithiole-3-thiones | |
| HK1256825A1 (en) | Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds | |
| GB201810668D0 (en) | New compounds | |
| GB201811169D0 (en) | New compounds | |
| GB201810669D0 (en) | New compounds | |
| EP3581770A4 (en) | Tappet | |
| DK3702546T3 (en) | Affaldsfrit, snitfrit sammensat træpanel til en træbygningskonstruktion | |
| EP3584416A4 (en) | Tappet | |
| DK3493849T3 (en) | New uses of n, n-bis-2-mercaptoethyl isophthalamide | |
| GB201709565D0 (en) | Compound | |
| GB201820544D0 (en) | Microcapsules | |
| GB201817634D0 (en) | New compounds | |
| GB201813681D0 (en) | New compounds | |
| GB201813574D0 (en) | A1 | |
| GB201801212D0 (en) | Microcapsules | |
| GB201717530D0 (en) | New compounds | |
| GB201805945D0 (en) | New compounds | |
| GB201804745D0 (en) | New compounds | |
| GB201801746D0 (en) | Hopevalley leads | |
| GB201714049D0 (en) | New compounds | |
| GB201802083D0 (en) | New compounds |